Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy

884 indexed citations
published 1999

Countries where authors are citing Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy

Specialization
Citations

This map shows the geographic impact of Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy more than expected).

Fields of papers citing Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

About Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy

This paper, published in 1999, received 884 indexed citations . Written by Krishnendu Roy, Hai‐Quan Mao, Shau Ku Huang and Kam W. Leong covering the research area of Immunology and Allergy, Biotechnology and Infectious Diseases. It is primarily cited by scholars working on Molecular Biology (394 citations), Pharmaceutical Science (197 citations) and Biomaterials (176 citations). Published in Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/7385.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026